The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AFYA | -12.14% | -43.49% | -10.78% | -38% |
| S&P | +16.9% | +95.99% | +14.39% | +128% |
Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $162.24M | 4.4% |
| Gross Profit | $101.77M | 7.2% |
| Gross Margin | 62.72% | 1.6% |
| Market Cap | $1.61B | 8.5% |
| Market Cap / Employee | $0.17M | 0.0% |
| Employees | 9.7K | 0.4% |
| Net Income | $31.15M | 0.1% |
| EBITDA | $66.80M | 10.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $201.38M | 54.6% |
| Accounts Receivable | $124.40M | 16.1% |
| Inventory | 0 | -100.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $358.95M | -20.3% |
| Short Term Debt | $231.95M | 529.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 7.78% | 0.5% |
| Return On Invested Capital | 7.15% | 0.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $32.62M | -18.1% |
| Operating Free Cash Flow | $40.44M | -8.1% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 13.62 | 12.05 | 13.39 | 13.35 | -7.22% |
| Price to Book | 2.15 | 1.90 | 2.34 | 2.10 | 0.74% |
| Price to Sales | 2.53 | 2.34 | 2.85 | 2.64 | 0.52% |
| Price to Tangible Book Value | -10.43 | -5.45 | -7.92 | -8.37 | 6.40% |
| Price to Free Cash Flow TTM | 9.32 | 8.03 | 10.26 | 11.80 | 28.70% |
| Enterprise Value to EBITDA | 34.09 | 30.99 | 26.57 | 30.40 | -6.81% |
| Free Cash Flow Yield | 10.7% | 12.4% | 9.8% | 8.5% | -22.30% |
| Return on Equity | 15.5% | 16.6% | 15.8% | 15.5% | -0.22% |
| Total Debt | $572.93M | $513.69M | $559.02M | $590.90M | 21.27% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
